ASND
Featured PickAscendis Pharma A/S
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
85
Entry Price
$231.05
Current Price
$10.84
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-22
Executive Summary
Ascendis Pharma (ASND) is flashing a high-conviction momentum breakout following the strategic redemption of its $575 million convertible notes due 2028. By forcefully retiring this debt overhang after shares surged past the 130% conversion threshold, management is signaling immense financial confidence and clearing the runway for further institutional accumulation. In a definitive RISK_ON regime that aggressively rewards fundamental improvements, this catalyst acts as the perfect ignition switch for a new momentum leg.
Technical Context
Setup
Explosive price action is confirmed by a massive 2.9x relative volume surge, positioning the stock just 7.5% shy of its 52-week high with top-tier ALPHA_MALE and BREAKOUT signals.
Invalidation (Stop)
The bullish thesis remains intact as long as the stock maintains its structural support at the $216.95 level.
Runner-ups
Recent Performance History
54 Total Picks • 53% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-21 | DBRG | $15.61 | $15.61 | +0.00% | N/A | N/A | N/A |
| 2026-04-20 | WAFD | $35.20 | $35.04 | -0.45% | N/A | N/A | N/A |
| 2026-04-17 | WAFD | $35.24 | $35.04 | -0.57% | N/A | N/A | N/A |
| 2026-04-16 | WABC | $53.71 | $53.91 | +0.37% | N/A | N/A | N/A |
| 2026-04-15 | ASND | $241.71 | $231.05 | -4.41% | -4.41% | N/A | N/A |
| 2026-04-13 | ASND | $248.55 | $231.05 | -7.04% | -1.28% | N/A | N/A |
| 2026-04-10 | DBRG | $15.55 | $15.61 | +0.39% | +0.26% | N/A | N/A |
| 2026-04-09 | PKBK | $29.80 | $29.84 | +0.13% | -1.58% | N/A | N/A |
| 2026-04-08 | PKBK | $29.15 | $29.84 | +2.37% | +1.23% | N/A | N/A |
| 2026-04-07 | FOLD | $14.47 | $14.46 | -0.07% | -0.07% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0